FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mitchel Kling

Research Profile

Disorders

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Physiology

Drug Resistance

Co-author Network

Publications

TOP 3
Subhajit Chakravorty; Michael A Grandner; Mitchel A Kling; Henry R Kranzler; Shahrzad Mavandadi; Michael L Perlis; David W Oslin
Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care.
Mitchel A Kling; Virginia M-Y Lee; John Q Trojanowski; David A Wolk; Steven E Arnold
Vascular disease and dementias: paradigm shifts to drive research in new directions.
Mark Yarchoan; Mitchel A Kling; Edward B Lee; Virginia M-Y Lee; Jon B Toledo; John Q Trojanowski; Vivianna M Van Deerlin; David A Wolk; Sharon X Xie; Steven E Arnold
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mitchel Kling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Subhajit Chakravorty; Michael A Grandner; Mitchel A Kling; Henry R Kranzler; Shahrzad Mavandadi; Michael L Perlis; David W Oslin
Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2013;22(3):266-70.
2013: Mitchel A Kling; Virginia M-Y Lee; John Q Trojanowski; David A Wolk; Steven E Arnold
Vascular disease and dementias: paradigm shifts to drive research in new directions.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2013;9(1):76-92.
2012: Mark Yarchoan; Mitchel A Kling; Edward B Lee; Virginia M-Y Lee; Jon B Toledo; John Q Trojanowski; Vivianna M Van Deerlin; David A Wolk; Sharon X Xie; Steven E Arnold
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.
Brain : a journal of neurology 2012;135(Pt 12):3749-56.
2012: Philip W Gold; Omer Bonne; Paul J Carlson; Dennis S Charney; Rene Costello; Gyorgy Csako; Wayne C Drevets; David Luckenbaugh; Alexander Neumeister; Maria G Pavlatou; Alan T Remaley; Mitchel A Kling
Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A.
Neuroscience letters 2012;520(1):1-5.
2011: Christian Grillon; Randi Heller; Elizabeth Hirschhorn; Mitchel A Kling; Daniel S Pine; Jay Schulkin; Meena Vythilingam
Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.
Biological psychiatry 2011;69(6):549-55.
2009: William T Regenold; Pornima Phatak; Christopher Mark Marano; Amritpal Sassan; Robert R Conley; Mitchel A Kling
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.
Biological psychiatry 2009;65(6):489-94.
2009: Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?
Depression and anxiety 2009;26(7):641-9.
2008: William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.
Journal of the neurological sciences 2008;275(1-2):106-12.
2008: Christina S Barr; Rachel L Dvoskin; Qiaoping Yuan; Robert H Lipsky; Manisha Gupte; Xian Hu; Zhifeng Zhou; Melanie L Schwandt; Stephen G Lindell; Megan McKee; Michelle L Becker; Mitchel A Kling; Phillip W Gold; Dee Higley; Markus Heilig; Stephen J Suomi; David Goldman
CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.
Archives of general psychiatry 2008;65(8):934-44.
2008: Linda L Carpenter; Lily Bayat; Francisco Moreno; Mitchel A Kling; Lawrence H Price; Audrey R Tyrka; Becky Kinkead; Michael J Owens; Charles Nemeroff
Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.
Psychiatry research 2008;157(1-3):123-9.
2007: Christian Grillon; Roman Duncko; Matthew F Covington; Lori Kopperman; Mitchel A Kling
Acute stress potentiates anxiety in humans.
Biological psychiatry 2007;62(10):1183-6.
2007: Mitchel A Kling; Salvatore Alesci; Gyorgy Csako; Rene Costello; David Luckenbaugh; Omer Bonne; Roman Duncko; Wayne C Drevets; Husseini K Manji; Dennis S Charney; Philip W Gold; Alexander Neumeister
Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.
Biological psychiatry 2007;62(4):309-13.
2007: Magdalena Tolea; Sandra A Black; Olivia Denise Carter-Pokras; Mitchel A Kling
Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(3):315-22.
2007: McDonald K Horne; Paula K Merryman; Ann M Cullinane; June Cai; Pedro E Martinez; Mitchel A Kling; Philip W Gold
Activation of blood coagulation in patients with major depressive disorder during euglycemic hyperinsulinemia.
Thrombosis research 2007;120(4):517-21.
2006: Holly A Garriock; Pedro Delgado; Mitchel A Kling; Linda L Carpenter; Michael Burke; William J Burke; Thomas Schwartz; Lauren B Marangell; Mustafa Husain; Robert P Erickson; Francisco A Moreno
Number of risk genotypes is a risk factor for major depressive disorder: a case control study.
Behavioral and brain functions : BBF 2006;2():24.
2005: H A Garriock; J J B Allen; Pedro Delgado; Z Nahaz; Mitchel A Kling; Linda Carpenter; M Burke; W Burke; T Schwartz; Lauren B Marangell; M Husain; R P Erickson; Francisco A Moreno
Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance.
Molecular psychiatry 2005;10(11):976-7.
2005: Mark Stork George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert H Howland; Mitchel A Kling; Francisco Moreno; Barry R Rittberg; David L Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip T Ninan; Paul Goodnick
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
Biological psychiatry 2005;58(5):364-73.
2005: A John Rush; Harold A Sackeim; Lauren B Marangell; Mark Stork George; Stephen K Brannan; Sonia M Davis; Philip W Lavori; Robert H Howland; Mitchel A Kling; Barry R Rittberg; Linda Carpenter; Philip T Ninan; Francisco Moreno; Thomas Schwartz; Charles Conway; Michael Burke; John J Barry
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Biological psychiatry 2005;58(5):355-63.
2005: A John Rush; Lauren B Marangell; Harold A Sackeim; Mark Stork George; Stephen K Brannan; Sonia M Davis; Robert H Howland; Mitchel A Kling; Barry R Rittberg; William J Burke; Mark H Rapaport; John M Zajecka; Andrew A Nierenberg; Mustafa M Husain; David Ginsberg; Robert G Cooke
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Biological psychiatry 2005;58(5):347-54.
2005: Philip W Gold; Ma-Li Wong; David S Goldstein; Herman K Gold; Donna S Ronsaville; Murray Esler; Salvatore Alesci; Anwar Masood; Julio Licinio; Thomas D Geracioti; Giulia Perini; Michael D DeBellis; Courtney Holmes; Alexandros N Vgontzas; Dennis S Charney; George Chrousos; Samuel M McCann; Mitchel A Kling
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(23):8303-8.
2005: Salvatore Alesci; Pedro E Martinez; Sujata Kelkar; Ioannis Ilias; Donna S Ronsaville; Samuel J Listwak; Alejandro Ayala; Julio Licinio; Herman K Gold; Mitchel A Kling; George Chrousos; Philip W Gold
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.
The Journal of clinical endocrinology and metabolism 2005;90(5):2522-30.
2005: Jason A Dominitz; Edward J Boyko; Thomas D Koepsell; Patrick J Heagerty; Charles Maynard; Jennifer L Sporleder; Andrew Stenhouse; Mitchel A Kling; William J M Hrushesky; Charles Zeilman; Stephen Sontag; Nikunj Shah; Fernando Ona; Bhupinder Anand; Marc Subik; Thomas F Imperiale; Samer Nakhle; Sam B Ho; Edmund J Bini; Bruce Lockhart; Jawad Ahmad; Anna Sasaki; Brian van der Linden; Doris H Toro; Jaime Martinez-Souss; Vivek Huilgol; Seth Eisen; Keith A Young
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.
Hepatology (Baltimore, Md.) 2005;41(1):88-96.
2004: Linda L Carpenter; Francisco A Moreno; Mitchel A Kling; george anderson; William T Regenold; David M Labiner; Lawrence H Price
Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Biological psychiatry 2004;56(6):418-26.
2004: Sally P Walsh; Mitchel A Kling
VNS and depression: current status and future directions.
Expert review of medical devices 2004;1(1):155-60.
2004: Paul E Ruskin; Michele Silver-Aylaian; Mitchel A Kling; Susan A Reed; Douglas D Bradham; J Richard Hebel; David Barrett; Frederick Knowles; Peter Hauser
Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatment.
The American journal of psychiatry 2004;161(8):1471-6.
2004: William T Regenold; Pornima Phatak; Mitchel A Kling; Peter Hauser
Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders.
Molecular psychiatry 2004;9(8):731-3.
2004: Ma-Li Wong; Julio Licinio; Bulent O Yildiz; Christos S Mantzoros; Paolo Prolo; Mitchel A Kling; Philip W Gold
Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments.
The Journal of clinical endocrinology and metabolism 2004;89(1):258-65.
2003: Thomas D Geracioti; Mitchel A Kling; Robert M Post; Philip W Gold
Antithyroid antibody-linked symptoms in borderline personality disorder.
Endocrine 2003;21(2):153-8.
2002: Peter Hauser; J Khosla; H Aurora; Jacqueline Laurin; Mitchel A Kling; J Hill; Mangla S Gulati; A J Thornton; R L Schultz; A D Valentine; C A Meyers; Charles D Howell
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.
Molecular psychiatry 2002;7(9):942-7.
2000: Mitchel A Kling; Richard E Carson; Lisa Borg; Alan J Zametkin; John A Matochik; James H Schluger; Peter Herscovitch; Kenner C Rice; Ann Ho; William Eckelman; Mary Jeanne Kreek
Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1070-6.
2000: Peter Hauser; R Soler; S Reed; R Kane; Mangla S Gulati; J Khosla; Mitchel A Kling; A D Valentine; C A Meyers
Prophylactic treatment of depression induced by interferon-alpha.
Psychosomatics 2000;41(5):439-41.
2000: William T Regenold; Mitchel A Kling; Peter Hauser
Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders.
Psychoneuroendocrinology 2000;25(6):593-606.
2000: Ma-Li Wong; Mitchel A Kling; P J Munson; Samuel J Listwak; Julio Licinio; P Prolo; BI Karp; I E McCutcheon; Thomas D Geracioti; Michael D DeBellis; Kenner C Rice; David S Goldstein; JD Veldhuis; George Chrousos; E H Oldfield; Samuel M McCann; Philip W Gold
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(1):325-30.
1998: Paul E Ruskin; S Reed; R Kumar; Mitchel A Kling; EVERETT SIEGEL; M Rosen; Peter Hauser
Reliability and acceptability of psychiatric diagnosis via telecommunication and audiovisual technology.
Psychiatric services (Washington, D.C.) 1998;49(8):1086-8.
1998: Alan D Valentine; Christina A Meyers; Mitchel A Kling; E Richelson; Peter Hauser
Mood and cognitive side effects of interferon-alpha therapy.
Seminars in oncology 1998;25(1 Suppl 1):39-47.
1998: Julio Licinio; Mitchel A Kling; Peter Hauser
Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
Seminars in oncology 1998;25(1 Suppl 1):30-8.